Company record · updated August 5, 2026
Chromacode Inc: 6 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs September 30, 2025 to March 31, 2026.
6observations
6source filings
6verified rows
2026-03-31most recent as-of date
Source rails for this company: N-PORT fund mark (6).
Reported by 2 filers: T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-03-31 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926326006593 |
| 2026-03-31 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926326006598 |
| 2025-12-31 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926326002544 |
| 2025-12-31 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926326002549 |
| 2025-09-30 | price per share | 4.8398 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 3029.71 / balance 626.0 [pp] | 000109926325003642 |
| 2025-09-30 | price per share | 4.8396 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 135.51 / balance 28.0 [pp] | 000109926325003637 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.